Title : Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.

Pub. Date : 2009 Sep

PMID : 19925388






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Human cytochrome P450 2C9 (CYP2C9) accounts for approximately 20% of total hepatic CYP content and metabolizes approximately 15% clinically used drugs including S-warfarin, tolbutamide, phenytoin, losartan, diclofenac, and celecoxib. Tolbutamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 Human cytochrome P450 2C9 (CYP2C9) accounts for approximately 20% of total hepatic CYP content and metabolizes approximately 15% clinically used drugs including S-warfarin, tolbutamide, phenytoin, losartan, diclofenac, and celecoxib. Tolbutamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens